National Peroxide Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals

Quality Assessment: Strong Financial Performance Bolsters Confidence

National Peroxide has delivered a very positive financial performance in the quarter ending March 2026, with net profit surging by an impressive 333.33%. The company reported a net profit after tax (PAT) of ₹10.34 crores over the latest six months, supported by record quarterly net sales of ₹85.68 crores and a highest-ever PBDIT of ₹14.88 crores. This marks the second consecutive quarter of positive results, signalling operational resilience and effective cost management.

Moreover, the company remains net-debt free, which enhances its financial stability and reduces risk for investors. However, the long-term growth outlook is less encouraging, with net sales declining at an annualised rate of 6.72% and operating profit shrinking by 24.68% over the past five years. This contrast between recent quarterly strength and subdued long-term growth tempers the overall quality rating.

Valuation: Attractive Metrics Amid Discount to Peers

From a valuation standpoint, National Peroxide presents a compelling case. The stock trades at a price-to-book value of 1, which is considered very attractive relative to its peers in the commodity chemicals industry. Its return on equity (ROE) stands at 3.2%, reflecting moderate profitability on shareholder funds. The company’s PEG ratio is a mere 0.1, indicating that earnings growth is substantially outpacing the stock price appreciation, which is a positive signal for value investors.

Despite these favourable valuation metrics, the stock’s market capitalisation remains in the micro-cap segment, which often entails higher volatility and liquidity risks. Over the past year, the stock has generated a return of 9.23%, outperforming the Sensex, which declined by 8.06% during the same period. This relative outperformance underscores the stock’s potential but also highlights the need for cautious optimism given its size and sector dynamics.

Financial Trend: Recent Earnings Momentum Contrasts with Long-Term Challenges

The company’s recent quarterly results have been very encouraging, with a significant spike in profitability and sales. The 333.33% growth in net profit for Q4 FY25-26 and the highest quarterly net sales and PBDIT figures reflect strong operational execution. This momentum is further supported by the company’s net-debt-free status, which provides financial flexibility for future investments or weathering market volatility.

However, the longer-term financial trend paints a more cautious picture. Over the last five years, National Peroxide’s net sales and operating profit have declined annually by 6.72% and 24.68%, respectively. This negative trajectory suggests structural challenges in sustaining growth, which investors should consider alongside the recent positive quarterly performance.

Technical Analysis: Downgrade Driven by Shift to Sideways Momentum

The primary catalyst for the downgrade from Buy to Hold is the change in the technical grade, which shifted from mildly bullish to sideways. Key technical indicators reveal a mixed picture. The weekly MACD remains bullish, but monthly signals are inconclusive. The weekly Bollinger Bands indicate mild bullishness, whereas the monthly bands have flattened to a sideways trend.

Daily moving averages have turned mildly bearish, signalling short-term weakness. The KST (Know Sure Thing) indicator on a weekly basis remains mildly bullish, but the Dow Theory shows no clear trend weekly and only mild bullishness monthly. The absence of strong momentum signals and the sideways technical stance suggest limited upside potential in the near term, prompting a more cautious rating.

On 14 May 2026, the stock closed at ₹640.60, down 0.90% from the previous close of ₹646.40. The 52-week high stands at ₹770.00, while the low is ₹350.00, indicating a wide trading range and volatility. The stock’s recent one-month return of 62.75% significantly outperformed the Sensex’s negative 2.91%, but the technical indicators warn of a potential pause or consolidation phase.

Investment Outlook: Hold Rating Reflects Balanced View

National Peroxide Ltd’s downgrade to a Hold rating by MarketsMOJO reflects a balanced assessment of its current standing. The company’s strong recent financial results, net-debt-free position, and attractive valuation metrics provide a solid foundation for investors. However, the downgrade is primarily driven by a deterioration in technical momentum and concerns over long-term growth trends.

Investors should weigh the company’s impressive short-term earnings growth and relative outperformance against the sideways technical signals and subdued five-year sales and profit trends. The stock’s micro-cap status also suggests higher risk and volatility, which may not suit all portfolios.

Overall, the Hold rating suggests that while National Peroxide remains a fundamentally sound company with potential upside, investors should exercise caution and monitor technical developments closely before committing additional capital.

Comparative Performance and Market Context

Over various time horizons, National Peroxide’s stock returns have been mixed but generally positive relative to the broader market. The one-week return was -1.2%, outperforming the Sensex’s -4.30%. The one-month return was a robust 62.75%, vastly exceeding the Sensex’s -2.91%. Year-to-date, the stock gained 36.88% while the Sensex declined 12.45%. Over one year, the stock returned 9.23% compared to the Sensex’s -8.06%. However, longer-term data for three, five, and ten years is not available for the stock, while the Sensex posted gains of 20.28%, 53.23%, and 192.70% respectively.

This relative outperformance in the short to medium term highlights the company’s recent operational improvements but also underscores the importance of monitoring its ability to sustain growth and technical momentum going forward.

Shareholding and Industry Position

The majority shareholding in National Peroxide is held by promoters, which often indicates stable ownership and alignment with shareholder interests. The company operates within the commodity chemicals sector, a space characterised by cyclical demand and pricing pressures. Its micro-cap status places it among smaller, potentially more volatile stocks within the industry.

Given these factors, the Hold rating reflects a prudent stance, recognising both the company’s strengths and the risks inherent in its market position and technical outlook.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →